110 related articles for article (PubMed ID: 25361003)
21. ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction.
Degoutin J; Brunet-de Carvalho N; Cifuentes-Diaz C; Vigny M
Eur J Neurosci; 2009 Jan; 29(2):275-86. PubMed ID: 19200234
[TBL] [Abstract][Full Text] [Related]
22. The presence of Y674/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma.
Youssef G; Gillett C; Rampling D; Chagtai T; Virasami A; Barton J; Edwards D; Sebire N; Anderson J; Montano X
Hum Pathol; 2019 Apr; 86():182-192. PubMed ID: 30594749
[TBL] [Abstract][Full Text] [Related]
23. NGF induces terminal differentiation in trkA expressing neuroblastoma cells in vitro and in vivo.
Matsushima H; Bogenmann E
Prog Clin Biol Res; 1994; 385():177-83. PubMed ID: 7972210
[No Abstract] [Full Text] [Related]
24. Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines.
Tonini GP; Casalaro A; Cara A; Di Martino D
Cancer Res; 1991 Mar; 51(6):1733-7. PubMed ID: 1998963
[TBL] [Abstract][Full Text] [Related]
25. Spatiotemporal expression of KHSRP modulates Schwann cells and neuronal differentiation after sciatic nerve injury.
Zhu X; Yao L; Yang X; Sun H; Guo A; Li A; Yang H
Int J Biochem Cell Biol; 2014 Mar; 48():1-10. PubMed ID: 24368152
[TBL] [Abstract][Full Text] [Related]
26. Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.
Zeine R; Salwen HR; Peddinti R; Tian Y; Guerrero L; Yang Q; Chlenski A; Cohn SL
Mod Pathol; 2009 Jul; 22(7):950-8. PubMed ID: 19407854
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
28. NTRK1/TrkA Activation Overrides the G
Hassiepen C; Soni A; Rudolf I; Boron V; Oeck S; Iliakis G; Schramm A
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885133
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
30. Glial differentiation of human adipose-derived stem cells: implications for cell-based transplantation therapy.
Tomita K; Madura T; Sakai Y; Yano K; Terenghi G; Hosokawa K
Neuroscience; 2013 Apr; 236():55-65. PubMed ID: 23370324
[TBL] [Abstract][Full Text] [Related]
31. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
Zeng G; Gao L; Birklé S; Yu RK
Cancer Res; 2000 Dec; 60(23):6670-6. PubMed ID: 11118051
[TBL] [Abstract][Full Text] [Related]
32. Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro.
Fryer RH; Kaplan DR; Kromer LF
Exp Neurol; 1997 Dec; 148(2):616-27. PubMed ID: 9417837
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of TrkA protein expression by miRNA‑92a promotes the proliferation and migration of human neuroblastoma cells.
Liao W; Zhang H; Feng C; Wang T; Zhang Y; Tang S
Mol Med Rep; 2014 Aug; 10(2):778-84. PubMed ID: 24839961
[TBL] [Abstract][Full Text] [Related]
34. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
35. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
36. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S
Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728
[TBL] [Abstract][Full Text] [Related]
37. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
Azar CG; Scavarda NJ; Nakagawara A; Brodeur GM
Prog Clin Biol Res; 1994; 385():169-75. PubMed ID: 7972209
[TBL] [Abstract][Full Text] [Related]
38. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
Henrich KO; Bauer T; Schulte J; Ehemann V; Deubzer H; Gogolin S; Muth D; Fischer M; Benner A; König R; Schwab M; Westermann F
Cancer Res; 2011 Apr; 71(8):3142-51. PubMed ID: 21385898
[TBL] [Abstract][Full Text] [Related]
39. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
[TBL] [Abstract][Full Text] [Related]
40. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG.
Gumy LF; Bampton ET; Tolkovsky AM
Mol Cell Neurosci; 2008 Feb; 37(2):298-311. PubMed ID: 18024075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
